EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Sulfite Oxidase in Relation to Oxidative Stress, Antioxidant Capacity and Inflammatory Response in Clear-Cell Renal-Cell Carcinoma—A Pilot Study

Corina Daniela Ene, Cosmin Ene, Ilinca Nicolae, Cristina Capusa, Madalina Irina Mitran, Cristina Iulia Mitran, Clara Matei, Ecaterina Rinja, Simona Roxana Georgescu, Mircea Tampa

Life · 13.11.2026 · 16 (11) · 1924

DOI: 10.3390/life16111924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 13.11.2026. Verfasst von Corina Daniela Ene und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carol Davila University of Medicine and Pharmacy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the factors that influence the sulfur compound circuit in clear-cell renal-cell carcinoma (ccRCC) is an important area of interest, particularly for studying pathomechanisms and developing personalized anticancer therapies. Sulfite oxidase (SUOX) is a versatile molecule and data on its serum levels in cancer patients are scarce. The majority of studies focus on assessing SUOX activity in tumor tissue. We conducted a pilot study and explored the role of SUOX in the pathophysiology of ccRCC, with particular emphasis on the potential effects of SUOX dysregulation. Using a prospective design, we assessed serum SUOX levels in 46 patients with localized ccRCC (T1N0M0) compared with 36 healthy controls and evaluated variations in SUOX levels in relation to clinicopathological characteristics and key processes implicated in renal tumorigenesis, including oxidative stress (assessed by 8-hydroxy-2′-deoxyguanosine (8-OHdG) and malondialdehyde (MDA)), inflammation (assessed by C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)), and antioxidant defense (assessed by total antioxidant status (TAS) and thiol–disulfide homeostasis parameters (thiols and disulfide levels)). Fasting blood samples were collected from ccRCC patients before surgery, processed, and analyzed using ELISA and standard laboratory methods to measure SUOX, 8-OHdG, MDA, CRP, ESR, TAS, albumin, thiols and disulfide levels. Compared with controls, ccRCC patients exhibited a significant decrease in serum SUOX levels (p < 0.001) and a marked increase in oxidative stress (as indicated by 8-OHdG and MDA levels, p < 0.001) and inflammation markers (including CRP and ESR, p < 0.001). TAS levels were significantly lower in ccRCC patients (p < 0.001). In addition, thiol–disulfide homeostasis was altered (significantly lower levels of thiols and significantly higher levels of disulfides, p < 0.05). SUOX levels correlated negatively with 8-OHdG, MDA, CRP, ESR, and disulfide levels, as well as with tumor size, but positively with TAS and thiol levels. These findings indicate that in patients with ccRCC, decreased levels of SUOX may be linked to high oxidative stress levels, altered antioxidant defense and exacerbated inflammatory response.

Förderung

  • Carol Davila University of Medicine and Pharmacy

Zitieren

APA

Ene, C. D., Ene, C., Nicolae, I., Capusa, C., Mitran, M. I., Mitran, C. I., Matei, C., Rinja, E., Georgescu, S. R., & Tampa, M. (2026). Serum Sulfite Oxidase in Relation to Oxidative Stress, Antioxidant Capacity and Inflammatory Response in Clear-Cell Renal-Cell Carcinoma—A Pilot Study. Life, 16(11), 1924. https://doi.org/10.3390/life16111924

Vancouver

Ene CD, Ene C, Nicolae I, Capusa C, Mitran MI, Mitran CI, et al. Serum Sulfite Oxidase in Relation to Oxidative Stress, Antioxidant Capacity and Inflammatory Response in Clear-Cell Renal-Cell Carcinoma—A Pilot Study. Life. 2026;16(11):1924. doi:10.3390/life16111924

BibTeX
@article{Ene2026,
  author = {Ene, Corina Daniela and Ene, Cosmin and Nicolae, Ilinca and Capusa, Cristina and Mitran, Madalina Irina and Mitran, Cristina Iulia and Matei, Clara and Rinja, Ecaterina and Georgescu, Simona Roxana and Tampa, Mircea},
  title = {Serum Sulfite Oxidase in Relation to Oxidative Stress, Antioxidant Capacity and Inflammatory Response in Clear-Cell Renal-Cell Carcinoma—A Pilot Study},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1924},
  doi = {10.3390/life16111924}
}
Kostenlos starten →